ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Syndrome
Pneumonia

COVID-19 trials near Berlin, BE, DEU:

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...

Enrolling
COVID-19
Bacterial Pneumonia
Drug: Placebo (human albumin 1%)
Drug: Trimodulin

Phase 3

Biotest

Berlin, Germany and 58 other locations

Objective of the study is to assess the safety and efficacy of CO2 removal by the multiECCO2R (CO2 Removal System) on the multiFiltrate/multiFiltrate...

Enrolling
Covid19
Hypercapnia
Device: multiECCO2R blood-gas exchanger
Fresenius Medical Care (FMC)

Berlin, Germany and 5 other locations

The goal of this clinical trial is to evaluate the therapeutic value of an approved drug (Vericiguat) in patients with post-COVID-19...

Enrolling
Post-COVID ME/CFS
Drug: Vericiguat Oral Tablet

Phase 2

Charité University Medicine Berlin
Charité University Medicine Berlin

Berlin, Germany

The main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A i...

Active, not recruiting
Hemophilia A
Drug: BAX 888

Phase 1, Phase 2

Baxalta
Baxalta

Berlin, Germany and 25 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo
Drug: Lecanemab

Phase 3

Eisai
Eisai

Berlin, Germany and 246 other locations

Locations recently updated

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Tozorakimab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 423 other locations

Status recently updated

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Enrolling
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Potsdam, Germany and 301 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

Berlin, Germany and 431 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

Berlin, Germany and 497 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems